ClinicalTrials.Veeva

Menu

Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

Sun Yat-sen University logo

Sun Yat-sen University

Status

Completed

Conditions

Liver Tumor
Hepatic Fibrosis

Treatments

Other: two-dimensional shear-wave elastography (SWE)

Study type

Observational

Funder types

Other

Identifiers

NCT02958592
2016-FXY-132

Details and patient eligibility

About

To evaluate the diagnostic performance of two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection, using resected tissue pathology as a reference standard.

Enrollment

121 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (i) patients with a solid focal liver lesion that was pathologically proven or diagnosed by imaging methods such as conventional US, CT or MR imaging; (ii) patients scheduled to undergo a hepatectomy; (iii) patients with a lesion ≥1.0 cm in diameter.

Exclusion criteria

  • (i) patients with a history of chemotherapy; (ii) patients unable to properly hold their breath.

Trial design

121 participants in 1 patient group

study group
Description:
patients with liver tumor intend to perform hepatectomy
Treatment:
Other: two-dimensional shear-wave elastography (SWE)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems